Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo , Japan.
Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Department of Rheumatology, School of Medicine, Tokyo Women's Medical University , Tokyo , Japan.
Mod Rheumatol. 2019 Sep;29(5):788-794. doi: 10.1080/14397595.2018.1519889. Epub 2018 Nov 28.
To evaluate the risk of hospitalized infection (HI), cardiovascular disease (CVD), stroke, and fracture in rheumatoid arthritis (RA) patients compared with non-RA patients using the Japanese health insurance database. Among individuals aged ≥18 years, RA cases were defined to have one RA diagnostic code and receiving ≥1 disease-modifying antirheumatic drug between 2005 and 2013 ( = 6,712). Age-, sex-, calendar year of the observation start-, and observation length-matched non-RA cases were selected at 1:5 ( = 33,560). Hazard ratios (HRs) were calculated using the time-dependent Cox regression analysis. Median age of the patients was 52.0 years. The incidence rates of HI, CVD, and fracture in the RA group were 2.42/100 person-years (PY), 4.94/1,000 PY, and 10.59/1,000 PY. The crude incidence rate ratios (95% CI) (RA vs. non-RA) for HI, CVD, and fracture were 2.47 (2.20-2.77), 1.89 (1.49-2.41), and 3.35 (2.80-4.02). The adjusted HR (95% CI) (RA vs. non-RA) was significantly elevated (HI, 1.74 [1.52-1.99], CVD, 1.38 [1.04-1.85], and fracture, 1.88 (1.54-2.31)]. The relatively young RA population had significantly higher risks of these complications than the non-RA, indicating importance of prevention of them even at young ages in clinical settings.
利用日本健康保险数据库,评估与非类风湿关节炎(RA)患者相比,RA 患者的住院感染(HI)、心血管疾病(CVD)、中风和骨折风险。在年龄≥18 岁的个体中,将 RA 病例定义为在 2005 年至 2013 年期间具有一个 RA 诊断代码并接受≥1 种疾病修饰抗风湿药物(DMARDs)( = 6,712)。选择年龄、性别、观察起始年份和观察长度匹配的非 RA 病例,比例为 1:5( = 33,560)。使用时间依赖性 Cox 回归分析计算风险比(HR)。患者的中位年龄为 52.0 岁。RA 组的 HI、CVD 和骨折发生率分别为 2.42/100 人年(PY)、4.94/1,000 PY 和 10.59/1,000 PY。HI、CVD 和骨折的粗发病率比(95%CI)(RA 与非 RA)分别为 2.47(2.20-2.77)、1.89(1.49-2.41)和 3.35(2.80-4.02)。调整后的 HR(95%CI)(RA 与非 RA)显著升高(HI,1.74[1.52-1.99];CVD,1.38[1.04-1.85];骨折,1.88[1.54-2.31])。RA 患者的年龄相对较小,这些并发症的风险明显高于非 RA 患者,这表明即使在年轻患者中,临床实践中也应重视这些并发症的预防。